Clinical trial

Targeting the Gut Dysbiosis to Treat Inflammation-driven Synaptopathy in MS

NCT05779449

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2023-07-26

PhaseNA

Study timeline

Study start (actual)2023-07-26Date precision: day

Registry last updated2023-08-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Patient Participationunresolved

Interventions

Prebiotics and Probiotics supplementationDIETARY_SUPPLEMENT

Placebo supplementationDIETARY_SUPPLEMENT

peripheral blood withdrawalPROCEDURE

Transcranial Magnetic Stimulation (TMS)PROCEDURE

Sponsors & collaborators

Neuromed IRCCSlead sponsor

I.R.C.C.S. Fondazione Santa Luciacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05779449 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.